CAS 69618-84-4

Medimeform

CAS: 69618-84-4

Medimeform is an anticancer drug that targets cancer cells by inhibiting the activity of kinases, which are enzymes that regulate various cellular processes. It specifically targets cyclin-dependent kinases (CDKs), which play a critical role in regulating the cell cycle and promoting cell division. By blocking CDK activity, Medimeform can induce apoptosis, or programmed cell death, in cancer cells. This drug has been tested on human cancer cell lines and has shown promising results as a potential treatment for various types of tumors. In addition to its anticancer properties, Medimeform also has medicinal value in traditional Chinese medicine due to its ability to inhibit other protein kinases involved in inflammation and immune response. Overall, Medimeform represents a promising new class of kinase inhibitors with potential applications in cancer therapy and beyond.

Formula: C₁₁H₁₆N₂•HCl

Purezza: Min. 95%

Peso molecolare: 212.72 g/mol

Ref: 3D-UCA61884